GENFIT Reaches A Critical Milestone Towards The Development Of A Non-Invasive In Vitro Diagnostic (IVD) Test For NASH Post author:Sam Post published:June 22, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Sarepta to Seek FDA Approval for Second DMD Treatment March 11, 2018 Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis February 12, 2018 Why This Tiny SoCal Biopharma Could be a Real Threat to Mylan May 29, 2017